1.
Consumer Corner: Foreclosure settlement no magic bullet for economy
SOUTH SAN FRANCISCO, Calif., Oct. 8 (UPI) -- Cellegy Pharmaceuticals of South San Francisco, Calif., said Friday it has agreed to acquire Biosyn Inc. of Huntingdon Valley, Pa.
Cellegy is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of gastrointestinal disorders, women's healthcare conditions and sexual dysfunction.
Biosyn Inc is a privately held biopharmaceutical company.
The addition of Biosyn, which leads in the development of a novel contraceptive gel, Savvy, for the prevention of HIV in women, expands Cellegy's near-term product pipeline and complements Cellegy's women's health focus.
Under terms of the deal, Cellegy will exchange of 2.5 million Cellegy common shares for all of Biosyn's issued and outstanding capital stock. Cellegy also will inject $3.25 million into the business in order to satisfy certain balance sheet liabilities and will pay up to an additional $15 million upon launch of Biosyn's lead product, Savvy in the United States and selected major overseas markets.
|
|
|
| Additional Business News Stories | |
SYDNEY, Feb. 13 (UPI) --
Researchers in Australia are developing a solar roof system that uses wasted energy to warm air and water.
|
SAINT-LAURENT, Quebec, Feb. 13 (UPI) --
The Canadian coast guard has picked Thales Canada for the supply and installation of helicopter tracking systems aboard 22 aircraft and 17 ships.
|
Local markets will probably not be swamped by waves of foreclosures following the multi-state mortgage settlement announced yesterday. Rather, the huge inventory of one to two million foreclosures will enter markets gradually....
|
Investors will not have the distraction of financial reports to look forward to this week. They will have to look at the spot news headlines instead.
|
| Stories | Photos | People | Comments |
View Caption
